Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Response: Protecting against Aspergillus infection in CGD

Abdul Hakkim, Robert Hurwitz, Matteo Bianchi, Volker Brinkmann, Ulrich Siler, Reinhard A. Seger, Arturo Zychlinsky, Janine Reichenbach

Blood (2009) 114 (16): 3498.

https://doi.org/10.1182/blood-2009-08-234054

Published: 2009

Journal Articles

Restoration of NET formation by gene therapy in CGD controls aspergillosis

Matteo Bianchi, Abdul Hakkim, Volker Brinkmann, Ulrich Siler, Reinhard A. Seger, Arturo Zychlinsky, Janine Reichenbach

Blood (2009) 114 (13): 2619–2622.

https://doi.org/10.1182/blood-2009-05-221606

Published: 2009

Includes: Supplemental data

Journal Articles

Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)

Patricia A. Taylor, Michael J. Ehrhardt, Christopher J. Lees, Jakub Tolar, Brenda J. Weigel, Angela Panoskaltsis-Mortari, Jonathan S. Serody, Volker Brinkmann, Bruce R. Blazar

Blood (2007) 110 (9): 3480–3488.

https://doi.org/10.1182/blood-2007-05-087940

Published: 2007

Journal Articles

FTY720 Inhibits Graft-Versus-Host Disease (GVHD) and Allogeneic Bone Marrow (BM) Graft Rejection Independent of Effects on T Cell Egress from Lymphoid Tissue.

Patricia A. Taylor, Michael J. Ehrhardt, Angela Panoskaltsis-Mortari, Jonathan S. Serody, Volker Brinkmann, Bruce R. Blazar

Blood (2006) 108 (11): 450.

https://doi.org/10.1182/blood.V108.11.450.450

Published: 2006

Journal Articles

The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34 + progenitor cells

Takafumi Kimura, Andreas M. Boehmler, Gabriele Seitz, Selim Kuçi, Tina Wiesner, Volker Brinkmann, Lothar Kanz, Robert Möhle

Blood (2004) 103 (12): 4478–4486.

https://doi.org/10.1182/blood-2003-03-0875

Published: 2004

NARROW

Response: Protecting against Aspergillus infection in CGD

Restoration of NET formation by gene therapy in CGD controls aspergillosis

Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)

FTY720 Inhibits Graft-Versus-Host Disease (GVHD) and Allogeneic Bone Marrow (BM) Graft Rejection Independent of Effects on T Cell Egress from Lymphoid Tissue.

The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34 + progenitor cells

Email alerts

ASH Publications

American Society of Hematology

Response: Protecting against Aspergillus infection in CGD

Restoration of NET formation by gene therapy in CGD controls aspergillosis

Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)

FTY720 Inhibits Graft-Versus-Host Disease (GVHD) and Allogeneic Bone Marrow (BM) Graft Rejection Independent of Effects on T Cell Egress from Lymphoid Tissue.

The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34 + progenitor cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only